Hypoglycemia
📧 Sign up to get email alerts when something new happens for Hypoglycemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Hypoglycemia (Low Blood Sugar) and the Heart [NA]
Completed clinical trial evaluating hypoglycemia in individuals with type 2 diabetes; results posted in 2020.
-
CLINICAL_TRIALS research · 2020-01-28Clinical Trial Update: Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes [NA]
A completed clinical trial assessing how mild hypoglycemia affects cognitive function in individuals with type 2 diabetes.
-
CLINICAL_TRIALS research · 2019-11-18Clinical Trial Update: Impact of Hypoglycaemia in Patients With Diabetes Mellitus Type 2 on Platelet Activation [NA]
Clinical trial update examining the impact of hypoglycemia on platelet activation in patients with type 2 diabetes mellitus.
-
EMA approval · 2019-10-18First non-injectable treatment for severe low blood sugar levels
EMA announces approval of the first non-injectable treatment for severe hypoglycemia, expanding options for management of severe low blood s…
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia [Phase 3]
Phase 3 trial update on the clinical usability of intranasal glucagon for treating hypoglycemia in diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus [Phase 1]
Phase 1 trial evaluating nasal glucagon in participants with type 1 diabetes completed with results posted.
-
FDA approval · 2019-09-10FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Original Application (Xeris Pharmaceuticals, Inc.)
FDA approved GVOKE HYPOPEN 0.5 mg Auto-Injector (glucagon injection, solution) from Xeris Pharmaceuticals in an original application (NDA212…
-
FDA approval · 2019-09-09FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for GLUCAGON submitted by Fresenius Kabi USA, LLC. The approval updates labeling and/or administ…
-
FDA approval · 2019-07-24FDA Approved: BAQSIMI — Original Application (Amphastar Pharmaceuticals, Inc.)
FDA approved BAQSIMI (glucagon) from Amphastar Pharmaceuticals in an Original Application for the treatment of severe hypoglycemia in people…
-
CLINICAL_TRIALS trial_result · 2019-05-30Clinical Trial Update: G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes [Phase 3]
Phase 3 trial comparing G-Pen to Lilly glucagon for hypoglycemia rescue in adults with type 1 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: SugarFACT - Sugar Requirements For African Children Trial [NA]
The SugarFACT trial evaluating sugar requirements for African children has been terminated, with conditions including hypoglycemia in non-di…
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Post Bariatric Closed Loop Glucagon Trial [NA]
Completed clinical trial investigating a post-bariatric closed-loop glucagon system for hypoglycemia; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients [Phase 2]
A Phase 2 clinical trial evaluated delivering G-Pump glucagon infusion via OmniPod to prevent hypoglycemia in post-bariatric surgery patient…
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics [Phase 3]
A Phase 3 trial comparing G-Pen to Lilly Glucagon for hypoglycemia rescue in adults with Type 1 diabetes has completed with posted results.
-
CLINICAL_TRIALS research · 2018-05-02Clinical Trial Update: Hypoglycaemia in People With Type 2 Diabetes in Primary Care
This update reports on a completed clinical trial studying hypoglycemia in people with type 2 diabetes managed in primary care (NCT02666521)…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes [Phase 2, Phase 3]
An update on a Phase 2/3 trial evaluating exenatide for impaired hypoglycaemic awareness in type 1 diabetes. The study has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Treatment of Hypoglycemia Following Gastric Bypass Surgery [Phase 4]
Phase 4 clinical trial evaluating treatment of hypoglycemia after gastric bypass surgery has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Hypoglycemia and Autonomic Nervous System Function [NA]
This clinical trial has completed and results have been posted. The study investigated how hypoglycemia affects autonomic nervous system fun…
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Outcomes Study of MTM in a Medicare ACO [NA]
This trial update notes the completion of an outcomes study evaluating medication therapy management (MTM) within a Medicare ACO, involving …
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Hypoglycemia and the Mineralocorticoid Receptor [NA]
A completed clinical trial investigating the relationship between the mineralocorticoid receptor and hypoglycemia, with results posted in 20…
-
CLINICAL_TRIALS research · 2017-10-19Clinical Trial Update: Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes [NA]
This entry notes the completion of a randomized crossover trial assessing a smartphone/tablet software tool for managing Type 1 diabetes, in…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial [NA]
Open-label demonstration trial comparing Glycosade (cornstarch) to gastrostomy tube–dextrose infusion for overnight euglycemia control in ch…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 Diabetes [Phase 4]
A Phase 4 trial assessed how ethanol (alcohol) intake affects the glucose response to subcutaneous glucagon in individuals with Type 1 diabe…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride [Phase 4]
Phase 4 trial comparing vildagliptin plus metformin versus vildagliptin plus glimepiride in adults with type 2 diabetes. The study completed…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients [Phase 2]
Phase 2 trial evaluating GLP-1(7-36) amide for glycemic control in critically ill patients was terminated; results have been posted.